PERSPECTIVE THERA.DL-,001PERSPECTIVE THERA.DL-,001PERSPECTIVE THERA.DL-,001

PERSPECTIVE THERA.DL-,001

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪987.20 M‬EUR
−0.09EUR
‪−42.14 M‬EUR
‪1.30 M‬EUR
‪466.28 M‬
Beta (1Y)
0.01

About Perspective Therapeutics, Inc.

CEO
Johan M. Spoor
Headquarters
Seattle
Employees (FY)
119
Founded
1998
FIGI
BBG000MFRDP6
Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers. The company was founded in 1998 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange PERSPECTIVE THERA.DL-,001 stocks are traded under the ticker AAJ.
PERSPECTIVE THERA.DL-,001 is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
AAJ earnings for the last quarter are −0.03 EUR per share, whereas the estimation was −0.03 EUR resulting in a 20.00% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about PERSPECTIVE THERA.DL-,001 earnings.
PERSPECTIVE THERA.DL-,001 revenue for the last quarter amounts to ‪271.80 K‬ EUR despite the estimated figure of ‪1.63 M‬ EUR. In the next quarter revenue is expected to reach ‪463.39 K‬ EUR.
Yes, you can track PERSPECTIVE THERA.DL-,001 financials in yearly and quarterly reports right on TradingView.
AAJ net income for the last quarter is ‪−9.80 M‬ EUR, while the quarter before that showed ‪−10.18 M‬ EUR of net income which accounts for 3.78% change. Track more PERSPECTIVE THERA.DL-,001 financial stats to get the full picture.
No, AAJ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AAJ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PERSPECTIVE THERA.DL-,001 stock right from TradingView charts — choose your broker and connect to your account.
AAJ reached its all-time high on May 21, 2015 with the price of 3.70 EUR, and its all-time low was 0.20 EUR and was reached on Nov 15, 2023. View more price dynamics on AAJ chart.
See other stocks reaching their highest and lowest prices.
As of May 7, 2024, the company has 119.00 employees. See our rating of the largest employees — is PERSPECTIVE THERA.DL-,001 on this list?
We've gathered analysts' opinions on PERSPECTIVE THERA.DL-,001 future price: according to them, AAJ price has a max estimate of 1.84 EUR and a min estimate of 1.38 EUR. Watch AAJ chart and read a more detailed PERSPECTIVE THERA.DL-,001 stock forecast: see what analysts think of PERSPECTIVE THERA.DL-,001 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PERSPECTIVE THERA.DL-,001 EBITDA is ‪−28.21 M‬ EUR, and current EBITDA margin is ‪−2.78 K‬%. See more stats in PERSPECTIVE THERA.DL-,001 financial statements.